Tele: 561.316.3330

Breaking Medical Device Industry News

Tuesday, October 26, 2021



Synchrony Medical and Sheba Medical Center Initiate 1st Clinical Trial Using a Personalized Chest Physiotherapy System for Patients Living with Chronic Lung Diseases

Synchrony Medical* is a medical device company developing a personalized chest physiotherapy system designed to provide efficient airway clearance. They recently initiated a clinical trial at The National Cystic Fibrosis Center of Israel, at Sheba Medical Center**.

Synchrony Medical notes the trial aims to test the functionality of the system and compare its airway clearance effectiveness to the standard of care solutions currently used in Cystic Fibrosis and Bronchiectasis patients.

“Effective airway clearance on a daily basis at home is the key to keeping chronic lung patients stable and breaking the vicious cycle of clinical deteriorations,” said Dr. Moshe Ashkenazi, Pediatric Pulmonologist, Deputy Director, Safra Children’s Hospital, Sheba Medical Center, and Synchrony Medical’s Co-founder.

Synchrony Medical has developed a novel airway clearance system based on a unique chest physiotherapy method developed at the National Cystic Fibrosis Center of Israel, Sheba Medical Center. The system includes real-time sensing for an adaptive treatment to achieve effective airway clearance.

“Our system will enable patients to receive state-of-the-art chest physiotherapy independently, in the comfort of their own home,” explained Anat Shani, CEO of Synchrony Medical. “By making this effective therapy accessible, Synchrony Medical will bring to patient’s years of experience from Sheba’s respiratory experts and may help minimize pulmonary exacerbations and costly hospitalization associated with chronic lung diseases. This trial brings us one step closer to our goal: improving the lives of millions of chronic lung disease patients who deserve better airway clearance solutions.”

Synchrony Medical is a portfolio company of MEDX Xelerator, a medical device incubator formed as an initiative of MEDX Ventures Group together with Boston Scientific, Intellectual Ventures and Sheba Medical Center.

*Synchrony Medical, a portfolio company of MEDX Xelerator, is a clinical stage medical device company innovating airway clearance for patients living with chronic lung diseases. Synchrony’s system will enable patients to receive high quality chest physiotherapy independently at the comfort of their home.

The system synchronizes a unique chest compression sequence and the delivery of positive airway pressure with the patient’s breathing cycle, according to a personalized treatment algorithm. It is based on a unique airway clearance method developed at the National CF Center of Israel, at the Sheba Medical Center.

**The largest and most comprehensive medical center in the Middle East, Sheba Medical Center, Tel Hashomer is generating global impact through its medical care, research and healthcare transformation. Sheba’s City of Health boasts an acute-care hospital, rehabilitation hospital, research and innovation hubs, medical simulation center and center for disaster response on one comprehensive campus in the center of Israel.

A university teaching hospital affiliated with the Sackler School of Medicine at Tel-Aviv University, Sheba is shaping the future of healthcare, educating the next generation of care providers. Sheba serves as a true hospital without borders, welcoming patients and healthcare professionals from all over the world and consistently providing the highest-level medical care to all in need. Sheba has been ranked a top-ten hospital in the world by Newsweek three years in a row (2019, 2020, 2021).

HCA Healthcare Names Dr. Michael Cuffe Executive Vice President, Chief Clinical Officer

HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced Michael...

Axix Resarch & Technologies Opens in Nashville

The Nashville location offers expansive fully functional operating labs for multi-skill training, private operating suites for smaller labs, large conference rooms, and configurable multi-purpose spaces.

Comar Evolves Brand to Assert Strength in Medical & Packaging Markets

“United under the Comar brand, the newly unveiled Comar Medical and Comar Packaging Solutions sub-brands reflect our broad range of capabilities and our deep expertise to meet the distinct demands of each market,” said Scott Conklin, Executive Vice President of Sales and Marketing.

Data Presented at ASTRO 2021 Validate Prognostic Value of Decipher Prostate Genomic Test in Newly Diagnosed, Clinically High-Risk Prostate Cancer

“This analysis provides the first clinical evidence that the Decipher Prostate classifier can help physicians and patients make critical, personalized treatment decisions in the post-biopsy, clinically high-risk prostate cancer setting,” said Elai Davicioni, Ph.D., Veracyte’s senior vice president of scientific and clinical operations, Urologic Cancers.
Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

By using this website you agree to accept Medical Device News Magazine Privacy Policy